Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899733-01-500021
Filing Date
2001-04-02
Accepted
2001-04-02 00:00:00
Documents
10
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 2000 10-K napro10k00.txt 10-K 204248
2 BYLAWS ex3-7.txt EX-3.7 61268
3 1993 PLAN AMENDMENT ex10-2.txt EX-10 1643
4 1994 PLAN AMENDMENT ex10-4.txt EX-10.4 6011
5 EUROPEAN AGREEMENT ex10-15.txt EX-10.15 65979
6 LICENSE AGREEMENT ex10-21.txt EX-10.21 47714
7 LEASE ex10-33.txt EX-10.33 24338
8 FORM OF SUBSCRIPTION AGREEMENT ex10-34.txt EX-10.34 92466
9 SUBSIDIARIES ex21.txt EX-21.1 299
10 E&Y CONSENT audcons00.txt EX-23.1 1750
  Complete submission text file 0000899733-01-500021.txt   508209
Mailing Address 6304 SPINE RD UNIT A BOULDER CO 80301
Business Address 6304 SPINE RD UNIT A BOULDER CO 80301 3035303891
NAPRO BIOTHERAPEUTICS INC (Filer) CIK: 0000891504 (see all company filings)

EIN.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24320 | Film No.: 1590710
SIC: 2833 Medicinal Chemicals & Botanical Products